Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.
2.
4.

Urinary chiro-inositol and myo-inositol excretion is elevated in the diabetic db/db mouse and streptozotocin diabetic rat.

Kawa JM, Przybylski R, Taylor CG.

Exp Biol Med (Maywood). 2003 Sep;228(8):907-14.

PMID:
12968062
5.

Effect of short- and long-term diabetes on carnitine and myo-inositol in rats.

Reddi AS, Jyothirmayi GN, DeAngelis B, Frank O, Baker H.

Comp Biochem Physiol A Comp Physiol. 1991;98(1):39-42.

PMID:
1673376
6.

Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus.

Kennington AS, Hill CR, Craig J, Bogardus C, Raz I, Ortmeyer HK, Hansen BC, Romero G, Larner J.

N Engl J Med. 1990 Aug 9;323(6):373-8.

9.

Isolation, structure, synthesis, and bioactivity of a novel putative insulin mediator. A galactosamine chiro-inositol pseudo-disaccharide Mn2+ chelate with insulin-like activity.

Larner J, Price JD, Heimark D, Smith L, Rule G, Piccariello T, Fonteles MC, Pontes C, Vale D, Huang L.

J Med Chem. 2003 Jul 17;46(15):3283-91.

PMID:
12852758
10.

Relationships of plasma C-peptide and gender to the urinary excretion of inositols in older people.

Campbell WW, Ostlund RE Jr, Joseph LJ, Farrell PA, Evans WJ.

Horm Metab Res. 2001 Jan;33(1):44-51.

PMID:
11280715
11.

Effect of cyclosporine treatment on carnitine and myo-inositol in diabetic rats.

Reddi AS, Jyothirmayi GN, Leevy CB, Khalil M, DeAngelis B, Frank O, Baker H.

Comp Biochem Physiol C. 1992;101(1):151-3.

PMID:
1350960
12.

Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats.

Farese RV, Standaert ML, Yamada K, Huang LC, Zhang C, Cooper DR, Wang Z, Yang Y, Suzuki S, Toyota T, et al.

Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11040-4.

13.

Phosphoinositol glycan derived mediators and insulin resistance. Prospects for diagnosis and therapy.

Larner J, Allan G, Kessler C, Reamer P, Gunn R, Huang LC.

J Basic Clin Physiol Pharmacol. 1998;9(2-4):127-37.

PMID:
10212830
14.

Elevated expression and activity of protein-tyrosine phosphatase 1B in skeletal muscle of insulin-resistant type II diabetic Goto-Kakizaki rats.

Dadke SS, Li HC, Kusari AB, Begum N, Kusari J.

Biochem Biophys Res Commun. 2000 Aug 11;274(3):583-9.

PMID:
10924321
15.

The significance of nerve sugar levels for the peripheral nerve impairment of spontaneously diabetic GK (Goto-Kakizaki) rats.

Suzuki K, Yen-Chung H, Toyota T, Goto Y, Hirata Y, Okada K.

Diabetes Res. 1990 May;14(1):21-5.

PMID:
2134662
16.
17.

Diabetes and the myo-inositol paradox.

Loy A, Lurie KG, Ghosh A, Wilson JM, MacGregor LC, Matschinsky FM.

Diabetes. 1990 Oct;39(10):1305-12.

PMID:
2210080
18.

Dietary myo-inositol therapy in hyperglycemia-induced embryopathy.

Khandelwal M, Reece EA, Wu YK, Borenstein M.

Teratology. 1998 Feb;57(2):79-84.

PMID:
9562680
19.

A stereospecific myo-inositol/D-chiro-inositol transporter in HepG2 liver cells. Identification with D-chiro-[3-3H]inositol.

Ostlund RE Jr, Seemayer R, Gupta S, Kimmel R, Ostlund EL, Sherman WR.

J Biol Chem. 1996 Apr 26;271(17):10073-8.

20.

Renal sorbitol, myo-inositol and glycerophosphorylcholine in streptozotocin-diabetic rats.

Schmolke M, Schleicher E, Guder WG.

Eur J Clin Chem Clin Biochem. 1992 Oct;30(10):607-14.

PMID:
1493153

Supplemental Content

Support Center